Log In
BCIQ
Print this Print this
 

Pentamer

  Manage Alerts
Collapse Summary General Information
Company City of Hope
DescriptionUniversal peptide vaccine composed of human cytomegalovirus envelope glycoprotein L (gL; UL115), human cytomegalovirus envelope glycoprotein H (gH; UL75), human cytomegalovirus uncharacterized protein UL128 (UL128), UL130 and UL131A antigens
Molecular Target Human cytomegalovirus (CMV) uncharacterized protein UL128 (UL128) ; Human cytomegalovirus (CMV) uncharacterized protein UL130 (UL130)
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationCytomegalovirus (CMV)
Indication DetailsPrevent congenital transmission of CMV; Treat and prevent cytomegalovirus (CMV)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$100.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/02/2015

$100.0M

Undisclosed

Undisclosed

Get a free BioCentury trial today